Propanc Biopharma (PPCB) Return on Assets (2012 - 2025)
Propanc Biopharma (PPCB) posted quarterly Return on Assets of 0.04% for Q4 2025, up 19.0% year-over-year from 0.03% in Q4 2024, and down 18.43% quarter-over-quarter from 0.03% in Q3 2025.
Propanc Biopharma (PPCB) Return on Assets (2012 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Return on Assets for 14 consecutive years, with 0.04% the latest figure, recorded in Q4 2025.
- In Q4 2025, Return on Assets rose 19.0% year-over-year to 0.04%; the TTM figure through Dec 2025 stood at 0.04% (up 19.0% YoY), while the FY2025 annual figure was 0.06%, up 21.0% from the prior year.
- Return on Assets slipped to 0.04% in Q4 2025 per PPCB's latest filing, from 0.03% in the prior quarter.
- Across five years, Return on Assets topped out at 0.01% in Q1 2021 and bottomed at 0.98% in Q2 2021.
- Historically, Return on Assets has averaged 0.24% across 5 years, with a median of 0.22% in 2022.
- On a YoY basis, Return on Assets climbed as much as 99 bps in 2021 and fell as far as 40 bps in 2021.
- Propanc Biopharma's Return on Assets stood at 0.29% in 2021, then grew by 15 bps to 0.24% in 2022, then soared by 52 bps to 0.12% in 2023, then plunged by 99 bps to 0.23% in 2024, then soared by 83 bps to 0.04% in 2025.
- Business Quant data shows PPCB's Return on Assets at 0.04% in Q4 2025, 0.03% in Q3 2025, and 0.03% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - | -0.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.04% |
| Sep 30, 2025 | -0.03% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | -0.05% |
| Dec 31, 2024 | -0.23% |
| Sep 30, 2024 | -0.27% |
| Jun 30, 2024 | -0.33% |
| Mar 31, 2024 | -0.16% |
| Dec 31, 2023 | -0.12% |
| Sep 30, 2023 | -0.20% |
| Jun 30, 2023 | -0.26% |
| Mar 31, 2023 | -0.22% |
| Dec 31, 2022 | -0.24% |
| Sep 30, 2022 | -0.32% |
| Jun 30, 2022 | -0.21% |
| Mar 31, 2022 | -0.18% |
| Dec 31, 2021 | -0.29% |
| Sep 30, 2021 | -0.56% |
| Jun 30, 2021 | -0.98% |
| Mar 31, 2021 | -0.01% |